Found: 9
Select item for more details and to access through your institution.
AML in the elderly—A global view.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 760, doi. 10.1111/bjh.19135
- By:
- Publication type:
- Article
Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 130, doi. 10.1111/bjh.15698
- By:
- Publication type:
- Article
An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34<sup>+</sup> CD38<sup>low</sup> blasts.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 80, doi. 10.1111/bjh.13398
- By:
- Publication type:
- Article
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1847, doi. 10.1002/ajh.27087
- By:
- Publication type:
- Article
Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia.
- Published in:
- Cancers, 2018, v. 10, n. 7, p. 215, doi. 10.3390/cancers10070215
- By:
- Publication type:
- Article
How Can We Improve on MRD Assessment by Flow Cytometry?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S49, doi. 10.1016/S2152-2650(21)01206-4
- By:
- Publication type:
- Article
MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 203, p. 1, doi. 10.1126/scitranslmed.3006061
- By:
- Publication type:
- Article
Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163291
- By:
- Publication type:
- Article
Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 3, p. 420, doi. 10.1046/j.1365-2141.2003.04625.x
- By:
- Publication type:
- Article